technetium tc 99m sestamibi has been researched along with Amyloid Neuropathy Type 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burniston, M; Fontana, M; Gilbertson, JA; Gillmore, JD; Hawkins, PN; Hutt, DF; Lachmann, HJ; Lane, T; Mahmood, S; Martinez-Naharro, A; Page, J; Petrie, A; Quarta, CC; Quigley, AM; Rezk, T; Ross, JC; Rowczenio, D; Sachchithanantham, S; Wechalekar, AD; Whelan, CJ; Youngstein, T | 1 |
1 other study(ies) available for technetium tc 99m sestamibi and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Topics: Adult; Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Amyloidosis; Cohort Studies; Echocardiography; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Muscle, Skeletal; Proportional Hazards Models; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Single Photon Emission Computed Tomography Computed Tomography; Statistics, Nonparametric; Survival Analysis; Technetium Tc 99m Sestamibi; Young Adult | 2017 |